Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Icecure Medical Ltd Ord (ICCM)

Icecure Medical Ltd Ord (ICCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 51,094
  • Shares Outstanding, K 45,620
  • Annual Sales, $ 3,230 K
  • Annual Income, $ -14,650 K
  • EBIT $ -4 M
  • EBITDA $ -15 M
  • 60-Month Beta 0.50
  • Price/Sales 14.67
  • Price/Cash Flow N/A
  • Price/Book 5.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.07
  • Number of Estimates 1
  • High Estimate -0.07
  • Low Estimate -0.07
  • Prior Year -0.07
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5600 +100.00%
on 11/21/24
1.1900 -5.88%
on 12/20/24
+0.5175 (+85.89%)
since 11/20/24
3-Month
0.4800 +133.33%
on 10/08/24
1.1900 -5.88%
on 12/20/24
+0.4800 (+75.00%)
since 09/20/24
52-Week
0.4800 +133.33%
on 10/08/24
1.5700 -28.66%
on 01/30/24
+0.1997 (+21.70%)
since 12/20/23

Most Recent Stories

More News
Alignment HealthCare Partners With Intermountain Health in Nevada

Alignment HealthCare, Inc.’s ALHC leading Medicare Advantage plan, Alignment Health Plan, is expanding its healthcare services in Nevada through a new agreement with Intermountain Health. Beginning Jan....

HQY : 94.95 (+0.20%)
ICCM : 1.1200 (-2.61%)
ALHC : 10.61 (+3.31%)
CODX : 0.7300 (+0.66%)
Zacks.com featured highlights Adverum Biotechnologies, IceCure, DarioHealth, Energous and Virgin Galactic

For Immediate ReleaseChicago, IL – October 3, 2024 – Stocks in this week’s article are Adverum Biotechnologies ADVM, IceCure Medical ICCM, DarioHealth DRIO, Energous WATT and Virgin Galactic SPCE.Bet...

WATT : 0.2910 (-1.69%)
ADVM : 4.74 (+0.85%)
DRIO : 0.8000 (+8.09%)
ICCM : 1.1200 (-2.61%)
SPCE : 6.10 (+2.01%)
Bet on 5 Top-Ranked Stocks With Rising P/E

Investors often opt for the stock-picking approach that involves stocks with a low price-to-earnings (P/E) ratio. This strategy is based on the notion that the lower the P/E ratio, the higher the stock...

WATT : 0.2910 (-1.69%)
ADVM : 4.74 (+0.85%)
DRIO : 0.8000 (+8.09%)
ICCM : 1.1200 (-2.61%)
SPCE : 6.10 (+2.01%)
As Early-Onset Breast Cancer Cases Soar in North America and EU, Biotech Ramps Up Response

/CNW/ -- USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In...

ONCY : 0.8310 (-6.36%)
ICCM : 1.1200 (-2.61%)
ATOS : 0.9637 (-1.66%)
ARVN : 18.48 (+3.65%)
PFE : 26.36 (+2.29%)
ONC.TO : 1.19 (-9.16%)
Biotech Firms Intensify Efforts as Breast Cancer Strikes Younger Patients at Alarming Rate

USA News Group – An alarming rise in early-onset cancers has medical experts very concerned, as cancer cases in younger people are rising sharply. In particular, a surge in cases of breast cancer is...

ONCY : 0.8310 (-6.36%)
ONC.TO : 1.19 (-9.16%)
ICCM : 1.1200 (-2.61%)
ATOS : 0.9637 (-1.66%)
ARVN : 18.48 (+3.65%)
PFE : 26.36 (+2.29%)
Renowned Spanish Radiologist Lucía Graña-López to Present Data Using IceCure Medical's ProSense at European Society of Breast Imaging Scientific Meeting 2023

/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation...

ICCM : 1.1200 (-2.61%)
IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer

/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM), developer of the ProSense® System, a minimally-invasive cryoablation technology that destroys tumors by...

ICCM : 1.1200 (-2.61%)
IceCure Medical to Join Hands-On Cryoablation Session with ProSense and Host Symposium Led by Renowned Doctors at the CIRCE 2023 Annual Congress

/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation...

ICCM : 1.1200 (-2.61%)
IceCure Medical Takes Next Major Initiative as it Prepares to Accelerate the Commercialization of ProSense in U.S. and Canada: Appoints VP of Sales, North America

Mr. Shad Good brings nearly 20 years of medical device sales and leadership experience, including as U.S. Senior Director of Sales at a global leader in...

ICCM : 1.1200 (-2.61%)
IceCure Medical Reports First Half 2023 Financial & Operational Results: Global Adoption of Cryoablation Technology Gaining Momentum

/PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure" or the "Company"), developer of the ProSense® System, a minimally-invasive cryoablation...

ICCM : 1.1200 (-2.61%)

Business Summary

IceCure Medical Ltd. develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. IceCure Medical Ltd. is based in CAESAREA, Israel.

See More

Key Turning Points

3rd Resistance Point 1.2500
2nd Resistance Point 1.2200
1st Resistance Point 1.1700
Last Price 1.1200
1st Support Level 1.0900
2nd Support Level 1.0600
3rd Support Level 1.0100

See More

52-Week High 1.5700
Fibonacci 61.8% 1.1536
Last Price 1.1200
Fibonacci 50% 1.0250
Fibonacci 38.2% 0.8964
52-Week Low 0.4800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar